NCT02631863View on ClinicalTrials.gov

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

November 24, 2018

Study Completion Date

November 24, 2018

Conditions

Cervical Intraepithelial NeoplasiaLow-Grade Squamous Intraepithelial LesionsPapillomavirus Infections

Interventions

DRUG

Aminolaevulinic acid

Aminolaevulinic acid with illumination

DRUG

Placebo

Placebo with illumination

Trial Locations (4)

100044

Peking University People's Hospital, Beijing

200011

The Obstetrics & Gynecology Hospital of Fudan University, Shanghai

250012

Qilu Hospital of Shandong University, Jinan

310006

Women's Hospital School of Medicine Zhejiang University, Hangzhou

All Listed Sponsors

lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT02631863 - Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) | Biotech Hunter | Biotech Hunter